DCAL
Dishman Carbogen Amcis Limited
Each stock's 10,000-path forecast, rendered as light.
Dishman Carbogen Amcis Limited (DCAL) Stock Analysis & Case Study
Is DCAL a good buy? The data-driven verdict.
Dishman Carbogen Amcis Limited (DCAL) trades at ₹193,on the numbers it tread carefully, a Downstox Snapshot Score of 34/100.
On the numbers, Dishman Carbogen Amcis Limited (DCAL) tread carefully, a Downstox Snapshot Score of 34/100, weighing premium at 30.5× earnings, ROE of 1.6%, a 47% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
DCAL fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How DCAL ranks against the 2,373 companies in our screener
- DCAL's market cap of 3,027 Cr ranks in the 58th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- DCAL's book value of ₹426 ranks in the 87th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- DCAL's promoter holding of 59.3% ranks in the 50th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- DCAL's 3-year profit (PAT) growth of 140.0% ranks in the top 3% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- DCAL's 3-year revenue growth of 7.0% ranks in the 41st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- DCAL's debt-to-equity ratio of 0.46x is lower than 38% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is DCAL overvalued? DCAL P/E vs peers
DCAL trades at 30.5× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
DCAL share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of DCAL history (1%/yr drift, 56%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| DCAL 2027 | ₹90 | ₹184 | ₹375 | -5% |
| DCAL 2028 | ₹64 | ₹175 | ₹480 | -9% |
| DCAL 2029 | ₹49 | ₹167 | ₹574 | -14% |
| DCAL 2030 | ₹38 | ₹159 | ₹669 | -18% |
| DCAL 2031 | ₹30 | ₹151 | ₹752 | -22% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability DCAL goes up, or doubles?
The bull case for DCAL
- Low price-to-book of 0.45×, the market is paying little over the company's net assets.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹574.
The bear case & risks
- DCAL's P/E of 30.5x is lower than 45% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- DCAL's return on equity of 1.6% ranks in the 18th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- High historical volatility (56%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹49.
DCAL volatility & expected range, how bumpy is the ride?
Over the last 9.8 years DCAL compounded at 1%/year with annualized volatility of 56%. That volatility implies a 1-year 80% range of ₹90-₹375, the honest backbone behind any single price target.
DCAL price forecast, the full 60-month probability fan
DCAL price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds DCAL hits common targets within the simulated horizon?
Full multi-horizon detail on the DCAL price target & forecast page.
DCAL Piotroski F-Score: 5/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. DCAL scores 5/8, mixed financial health.
DCAL MTF margin & leverage across 10 brokers
Margin Trading Facility lets you buy DCAL with part of the capital. Lower margin % = higher leverage. Rates compared across 10 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 40.16% | 2.5× |
| ZerodhaCHEAPEST | 40.10% | 2.5× |
| Groww | 40.33% | 2.5× |
| DhanCHEAPEST | 40.10% | 2.5× |
| Kotak Neo | 100.00% | 1.0× |
| Paytm Money | 40.22% | 2.5× |
| Pocketful | 40.85% | 2.4× |
| Fyers | 50.00% | 2.0× |
| Bajaj Broking | 45.00% | 2.2× |
| Share India | 40.27% | 2.5× |
Compare every broker on the DCAL MTF page.
About Dishman Carbogen Amcis Limited: sector, index & market-cap context
Dishman Carbogen Amcis Limited (DCAL) is a small-cap NSE-listed company, with a market capitalisation of ₹3,027 Cr. See more stocks on our screener.
How the DCAL Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Dishman Carbogen Amcis Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
DCAL analysis, FAQs
Is Dishman Carbogen Amcis Limited (DCAL) a good buy?
On the numbers, Dishman Carbogen Amcis Limited (DCAL) tread carefully, a Downstox Snapshot Score of 34/100, weighing premium at 30.5× earnings, ROE of 1.6%, a 47% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is DCAL overvalued or undervalued?
DCAL trades at 30.5× earnings, premium versus the ~22× long-run Nifty average.
What is the DCAL share price target for 2031?
DCAL's probability-weighted 2031 median target is ₹151, with an 80% range of ₹30-₹752 (10,000-path Monte-Carlo).
What is the probability DCAL doubles in 5 years?
The modelled probability of DCAL reaching ₹386 (2×) within 5 years is 23%.
What is the bull case for DCAL?
Low price-to-book of 0.45×, the market is paying little over the company's net assets.
What are the risks in DCAL?
DCAL's P/E of 30.5x is lower than 45% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. DCAL's return on equity of 1.6% ranks in the 18th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026. High historical volatility (56%/yr) means a wide, bumpy range of outcomes, size positions accordingly.